Picture of Zealand Pharma A/S logo

ZEAL Zealand Pharma A/S News Story

0.000.00%
dk flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapNeutral

Brief: Zealand Pharma, OTR Therapeutics Enter Strategic Collaboration

Dec 11 (Reuters) - Zealand Pharma A/S ZELA.CO:

ZEALAND PHARMA AND OTR THERAPEUTICS ENTER MULTI-PROGRAM STRATEGIC COLLABORATION AND LICENSE AGREEMENT TO DEVELOP NOVEL THERAPEUTICS FOR METABOLIC DISEASES

OTR THERAPEUTICS TO RECEIVE INITIAL USD 20 MILLION

OTR THERAPEUTICS ELIGIBLE FOR TOTAL CONSIDERATION UP TO USD 2.5 BILLION

Source text: ID:nGNE1tTWVV

Further company coverage: ZELA.CO

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Zealand Pharma A/S

See all news